Clinical Significance of Coagulation Assays in Metastatic Pancreatic Adenocarcinoma
Authors:
- 14 June 2013
- journal article
- research article
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 44 (4) , 404-409
Abstract
Activated coagulation and fibrinolytic system in cancer patients is associated with tumor stroma formation and metastasis in different cancer types. The aim of this study is to explore the correlation of blood coagulation tests for various clinicopathologic factors in patients with metastatic pancreatic adenocarcinoma (MPA). A total of 17 MPA patients were enrolled into the study. All the patients were treatment-naïve. Pretreatment blood coagulation tests including prothrombin time, activated partial thromboplastin time (APTT), international normalized ratio (INR), D-dimer, fibrinogen levels, and platelet counts were evaluated. Control group comprised 50 age- and sex-matched individuals without history of malignancy and coagulation disorder. Median age of diagnosis was 59 years old (range, 35–72). The plasma level of all coagulation factors revealed statistically significant difference between patient and control group (p < 0.01). Anemic patients had associated with higher D-dimer levels (p = 0.001). Similarly, the ones with elevated serum CA19-9 exhibited significantly higher D-dimer values (p = 0.011). For APTT, significant differences were found in both between gender of patients (p = 0.01) and response to chemotherapy (p = 0.01). The patients with elevated erythrocyte sedimentation rates had associated with higher INR (p = 0.05). Univariate analysis of survival revealed that the patients with unresponsive to chemotherapy (p = 0.06) and higher INR (p = 0.078) had poor overall outcome. Serum D-dimer level is elevated among MPA patients with higher serum CA19-9 and higher INR levels seem to be a poor prognostic factor in MPA.Keywords
This publication has 30 references indexed in Scilit:
- High D-dimer levels are associated with poor prognosis in cancer patientsHaematologica, 2012
- Plasma Fibronectin Promotes Lung Metastasis by Contributions to Fibrin Clots and Tumor Cell InvasionCancer Research, 2010
- Cancer, Clots and Consensus: New Understanding of an Old ProblemJournal of Clinical Oncology, 2009
- D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis StudyJournal of Clinical Oncology, 2009
- Anticoagulation for the initial treatment of venous thromboembolism in patients with cancerCancer, 2008
- Coagulation, anticoagulation and pancreatic carcinomaNature Clinical Practice Gastroenterology & Hepatology, 2008
- The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancerEuropean Journal of Surgical Oncology, 2005
- Involvement of lnterleukin-6 in the Elevation of Plasma Fibrinogen Levels in Lung Cancer PatientsJapanese Journal of Clinical Oncology, 1998
- Haemostatic abnormalities in lung cancer: Prognostic implicationsEuropean Journal of Cancer, 1997
- Plasma D‐dimer and peritoneal CA‐125 levels as predictors of disease status in ovarian carcinomaJournal of Surgical Oncology, 1994